◀ Back to RELA

ATL2 — RELA

Text-mined interactions from Literome

Ohsugi et al., Carcinogenesis 2005 (Disease Models, Animal...) : To examine the effect of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin ( DHMEQ ), on ATL in vivo, we developed an improved severe combined immunodeficiency (SCID) mouse model for ATL
Watanabe et al., Blood 2005 (Leukemia, T-Cell...) : We conclude that NF-kappaB is a potential molecular target for treatment and prevention of ATL
Cezar-de-Mello et al., Br J Pharmacol 2008 (Neovascularization, Pathologic) : Because the transcription factor NF-kappaB has been implicated in VEGF mediated MMP expression and EC proliferation, we postulated that ATL-1 might modulate the NF-kappaB pathway and, indeed, ATL-1 inhibited NF-kappaB nuclear translocation